[1]
GOLOVENKO, M. et al. 2025. IN VITRO ASSESSMENT OF REVERSIBLE AND METABOLISM-DEPENDENT INHIBITORY EFFECTS OF PROPOXAZEPAM ON CYP2C8 ACTIVITY. Experimental Oncology. 47, 1 (Jul. 2025), 51–59. DOI:https://doi.org/10.15407/exp-oncology.2025.01.051.